Loading…
Loading…
The iShares High Yield Muni Active ETF (HIMU) is an actively managed portfolio holding approximately 900 municipal bonds.
Muni ETFs just posted record inflows. Jim Colby on why low volatility, strong risk-adjusted returns, and tax-advantaged yields keep drawing investors in.
A married couple filing jointly with $400,000 of taxable income occupies one of the highest tax brackets many affluent retirees and professionals will encounter before reaching the top tier. At that income level, federal taxes already take a meaningful bite out of interest income, and investors in high-tax states can face an even steeper combined burden.... This $750,000 Municipal Bond Sleeve Pays a High-Earner Couple $33,000 a Year of Federal-Tax-Free Income
The 10-year Treasury yields 4.43%, which sounds competitive until a high earner runs it through the tax screen.
When advisors and investors hear the terms “high yield” or “junk” as it relates to bonds, they understandably have some apprehension. After all, junk bonds carry elevated credit risk relative to their investment-grade peers.
HYD is a muni bond ETF, investing in both high-yield and investment-grade muni bonds. It has a tax-advantaged 4.4% yield, which should provide above-average income to some investors in higher tax brackets. It seems broadly inferior to FLMI, another muni bond ETF, with higher-quality holdings and stronger performance.
As we navigate the first quarter of 2026, advisor interest is increasingly shifting toward traditional hedges and quality-oriented products. VanEck, a pioneer in thematic and hard-asset investing, has seen its lineup take center stage as market participants grapple with a shifting macro environment.
TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia's next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor would eliminate the use of an external driver and offer both greater convenience and increased freedom related to patient mobility.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for HYD and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.